Literature DB >> 28327056

Multiple sclerosis and suicide.

Anthony Feinstein1, Bennis Pavisian1.   

Abstract

Mortality rates are elevated in people with multiple sclerosis (MS) relative to the general population. There is, however, some uncertainty whether suicide contributes to this. Epidemiological data suggest that the standardized mortality ratio (SMR) for suicide in MS is approximately twice that of the general population with younger males in the first few years following diagnosis most at risk. Rates of suicidal intent, a potential harbinger of more self-destructive behavior, are also elevated, but the frequency with which intent is followed by suicide is not known. Depression, severity of depression, social isolation, and alcohol abuse are associated with thoughts of suicide. The variables linked with suicide and suicidal intent are therefore well defined and should be readily available from routine clinical inquiry. While vigilance on the part of clinicians is required, particularly in the context of high-risk patients, it is also recognized that prevention is dependent on full disclosure of intent.

Entities:  

Keywords:  Multiple sclerosis; standardized mortality ratio; suicide

Mesh:

Year:  2017        PMID: 28327056     DOI: 10.1177/1352458517702553

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  18 in total

1.  Depression Comorbid With Stroke, Traumatic Brain Injury, Parkinson's Disease, and Multiple Sclerosis: Diagnosis and Treatment.

Authors:  Susan K Conroy; Katherine B Brownlowe; Thomas W McAllister
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-04-23

2.  Relationship Between Interpersonal Depressive Symptoms and Reduced Amygdala Volume in People with Multiple Sclerosis: Considerations for Clinical Practice.

Authors:  Sarah Haines; Ernest Butler; Stephen Stuckey; Robert Hester; Lisa B Grech
Journal:  Int J MS Care       Date:  2020-12-15

3.  Education Research: Multiple sclerosis and neuroimmunology fellowship training status in the United States.

Authors:  Ahmed Z Obeidat; Yasir N Jassam; Le H Hua; Gary Cutter; Corey C Ford; June Halper; Robert P Lisak; Nancy L Sicotte; Erin E Longbrake
Journal:  Neurology       Date:  2020-02-27       Impact factor: 11.800

4.  Prevalence of somatic and psychiatric morbidity across occupations in Switzerland and its correlation with suicide mortality: results from the Swiss National Cohort (1990-2014).

Authors:  M Schmid; L Michaud; N Bovio; I Guseva Canu
Journal:  BMC Psychiatry       Date:  2020-06-22       Impact factor: 3.630

5.  Longitudinal Associations of Modifiable Lifestyle Factors With Positive Depression-Screen Over 2.5-Years in an International Cohort of People Living With Multiple Sclerosis.

Authors:  Keryn L Taylor; Steve Simpson; George A Jelinek; Sandra L Neate; Alysha M De Livera; Chelsea R Brown; Emily O'Kearney; Claudia H Marck; Tracey J Weiland
Journal:  Front Psychiatry       Date:  2018-10-30       Impact factor: 4.157

Review 6.  Multiple Immune-Inflammatory and Oxidative and Nitrosative Stress Pathways Explain the Frequent Presence of Depression in Multiple Sclerosis.

Authors:  Gerwyn Morris; Edna Maria Vissoci Reiche; Andrea Murru; André F Carvalho; Michael Maes; Michael Berk; Basant K Puri
Journal:  Mol Neurobiol       Date:  2018-01-02       Impact factor: 5.590

7.  Psychometric properties of the PHQ-9 depression scale in people with multiple sclerosis: A systematic review.

Authors:  Sarah Patrick; Peter Connick
Journal:  PLoS One       Date:  2019-02-19       Impact factor: 3.240

Review 8.  Cognitive and neuropsychiatric disorders among MS patients from Latin America.

Authors:  Sandra Vanotti; Fernando J Caceres
Journal:  Mult Scler J Exp Transl Clin       Date:  2017-09-25

9.  The Main Determinants for Suicidal Ideation in a Romanian Cohort of Multiple Sclerosis Patients.

Authors:  Andreea Romaniuc; Rodica Bălaşa; Nicoleta Ştirbu; Smaranda Maier; Sebastian Andone; Zoltan Bajko; Laura Bărcuţean; Septimiu Voidăzan; Anca Moţăţăianu
Journal:  Behav Neurol       Date:  2020-01-21       Impact factor: 3.342

Review 10.  The Rationale for Monitoring Cognitive Function in Multiple Sclerosis: Practical Issues for Clinicians.

Authors:  Christos Bakirtzis; Panagiotis Ioannidis; Lambros Messinis; Grigorios Nasios; Elina Konstantinopoulou; Panagiotis Papathanasopoulos; Nikolaos Grigoriadis
Journal:  Open Neurol J       Date:  2018-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.